These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12113059)

  • 1. Hormonal treatment of endometrial carcinoma.
    Baekelandt M
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):106-12. PubMed ID: 12113059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormone therapy of endometrial carcinoma].
    Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R
    Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal therapy of endometrial stromal sarcoma.
    Reich O; Regauer S
    Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data.
    Polyzos NP; Pavlidis N; Paraskevaidis E; Ioannidis JP
    Eur J Cancer; 2006 Feb; 42(3):319-26. PubMed ID: 16376072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal therapy of endometrial cancer.
    Markman M
    Eur J Cancer; 2005 Mar; 41(5):673-5. PubMed ID: 15763641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
    Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
    Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to chemotherapy and hormone therapy in endometrial cancer.
    Chaudhry P; Asselin E
    Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal therapies and gynaecological cancers.
    Garrett A; Quinn MA
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):407-21. PubMed ID: 17884734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy.
    Takahashi N; Hirashima Y; Harashima S; Takekuma M; Kawaguchi R; Yamada Y; Ito I
    Arch Gynecol Obstet; 2008 Oct; 278(4):365-7. PubMed ID: 18273628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy in metastatic or recurrent endometrial cancer.
    Pectasides D; Pectasides E; Economopoulos T
    Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.
    Hogberg T
    Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):463-9. PubMed ID: 18467080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal treatment of endometrial cancer.
    Emons G; Heyl W
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):619-23. PubMed ID: 11079725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of endometrial cancer.
    Barrena Medel NI; Bansal S; Miller DS; Wright JD; Herzog TJ
    Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of estrogen actions in human gynecological malignancies: new aspects of endocrine therapy for endometrial cancer and ovarian cancer.
    Ito K; Utsunomiya H; Niikura H; Yaegashi N; Sasano H
    Mol Cell Endocrinol; 2011 Jul; 340(2):161-7. PubMed ID: 21111773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant endocrine therapy for locally advanced breast cancer.
    Ma CX; Ellis MJ
    Semin Oncol; 2006 Dec; 33(6):650-6. PubMed ID: 17145344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.
    Alkasi O; Meinhold-Heerlein I; Zaki R; Fasching P; Maass N; Jonat W; Beckmann MW
    Arch Gynecol Obstet; 2009 Jan; 279(1):57-60. PubMed ID: 18379806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hormone treatment of early endometrial cancer].
    Ivanov S; Ivanov S; Kŭrlov T; Milev A; Kulander S; Ivanov V
    Akush Ginekol (Sofiia); 1999; 38(1):20-3. PubMed ID: 11965713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.